2023
Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan
Blechter B, Chien L, Chen T, Chang I, Choudhury P, Hsiao C, Shu X, Wong J, Chen K, Chang G, Tsai Y, Su W, Huang M, Chen Y, Chen C, Hung H, Hu J, Shi J, Zheng W, Rositch A, Chen C, Chatterjee N, Yang P, Rothman N, Hsiung C, Lan Q. Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan. JAMA Network Open 2023, 6: e2339254. PMID: 37955902, PMCID: PMC10644212, DOI: 10.1001/jamanetworkopen.2023.39254.Peer-Reviewed Original ResearchConceptsEnvironmental tobacco smokeAbsolute riskLung adenocarcinomaPolygenic risk scoresETS exposureTobacco smokeRisk scoreLung cancer risk factorsLung cancer screening programsGenetic susceptibilityLung cancer incidence ratesLifetime absolute riskCancer screening programsCancer risk factorsCase-control studyCancer incidence ratesRelative risk estimatesOverall genetic susceptibilitySuper-additive interactionRecent genome-wide association studiesLung cancerIncidence rateRisk factorsScreening programMAIN OUTCOMEImpact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network
Udelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.Peer-Reviewed Original ResearchHealth care networkLung cancer screening processLung cancer screening programsCare networkCancer screening programsCoronavirus disease 2019 (COVID-19) pandemicComputed tomography scanCOVID-19 hospitalizationCOVID-19 surgeCancer screening processDisease 2019 pandemicLung cancer diagnosisHealth care systemAverage hospitalizationRadiology databaseLung cancerTomography scanScreening programCare systemCancer diagnosisMonthsHospitalizationCOVID-19COVID-19 pandemicPandemicBend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic
Stahl M, Shamah S, Wattamwar K, Furlani A, Serrano M, Haramati L. Bend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic. Clinical Imaging 2023, 100: 1-6. PMID: 37120922, PMCID: PMC10129344, DOI: 10.1016/j.clinimag.2023.04.011.Peer-Reviewed Original ResearchConceptsCancer screening programsLung cancer screening programsScreening programLung cancerPre-pandemic periodCOVID-19 pandemicLung-RADS scorePercentage of examsPandemic periodFirst yearRetrospective cohortAppropriate followPandemic surgeScreening volumeHigh mortalityPatientsCOVID surgeNew York StateCancerCOVID-19Significant differencesDemographic subgroupsCohortFollowInner-city programLung Cancer Screening Penetration in an Urban Underserved County
Lee K, Haramati L, Ye K, Lin J, Mardakhaev E, Gohari A. Lung Cancer Screening Penetration in an Urban Underserved County. Lung 2023, 201: 243-249. PMID: 36892635, DOI: 10.1007/s00408-023-00609-7.Peer-Reviewed Original ResearchConceptsLung cancer screening programsCancer screening programsRace/ethnicityLung cancerScreening programSocioeconomic statusMethodsThis retrospective cohort studyRetrospective cohort studyInstitutional review board approvalLung cancer screeningUrban medical centerReview board approvalSignificant differencesTwo-sample t-testLower SES neighborhoodsCohort studyMore patientsHispanic patientsCancer screeningCancer cohortUnderserved countiesInclusion criteriaMedical CenterBoard approvalPatients
2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report
Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report. CHEST Journal 2020, 158: 406-415. PMID: 32335067, PMCID: PMC7177089, DOI: 10.1016/j.chest.2020.04.020.Peer-Reviewed Original ResearchConceptsLung cancer screeningStage I non-small cell lung cancerNon-small cell lung cancerCell lung cancerCancer screeningLung nodule evaluationConsensus statementLung nodulesLung cancerClinical stage I non-small cell lung cancerNodule evaluationAnnual lung cancer screeningHigh-risk lung nodulesLung cancer screening programsCHEST Expert Panel ReportCurrent guideline recommendationsCancer screening programsPatient-related factorsCommon clinical scenariosCoronavirus disease 2019Balance of benefitsIndividual patient careCOVID-19 pandemicExpert Panel ReportPotential exposureManagement of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report
Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report. Journal Of The American College Of Radiology 2020, 17: 845-854. PMID: 32485147, PMCID: PMC7177099, DOI: 10.1016/j.jacr.2020.04.024.Peer-Reviewed Original ResearchConceptsLung cancer screeningCell lung cancerCancer screeningLung nodule evaluationConsensus statementLung nodulesLung cancerStage INodule evaluationAnnual lung cancer screeningHigh-risk lung nodulesLung cancer screening programsClinical stage ICHEST Expert Panel ReportCurrent guideline recommendationsCancer screening programsPatient-related factorsCommon clinical scenariosCoronavirus disease 2019Balance of benefitsIndividual patient careCOVID-19 pandemicExpert Panel ReportPotential exposureGuideline recommendationsManagement of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiology Imaging Cancer 2020, 2: e204013. PMID: 33778716, PMCID: PMC7233408, DOI: 10.1148/rycan.2020204013.Peer-Reviewed Original ResearchConceptsLung cancer screeningStage I non-small cell lung cancerNon-small cell lung cancerCell lung cancerCancer screeningLung nodule evaluationConsensus statementLung nodulesLung cancerClinical stage I non-small cell lung cancerNodule evaluationAnnual lung cancer screeningHigh-risk lung nodulesLung cancer screening programsCurrent guideline recommendationsCancer screening programsPatient-related factorsCommon clinical scenariosCoronavirus disease 2019Balance of benefitsIndividual patient careCOVID-19 pandemicPotential exposureGuideline recommendationsSurveillance imagingPerformance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort
Kessler A, Peng R, Mardakhaev E, Haramati L, White C. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort. Radiology Imaging Cancer 2020, 2: e190021. PMID: 33778703, PMCID: PMC7983652, DOI: 10.1148/rycan.2020190021.Peer-Reviewed Original ResearchConceptsLung CT Screening ReportingLung-RADSFalse-negative findingsRadiology's Lung CT Screening ReportingLung cancer screening cohortAccountability Act-compliant retrospective studyLung cancer screening programsLung-RADS scoreInstitutional review board approvalCancer screening programsLung nodulesLung cancer screeningRisk of cancerReview board approvalDiverse clinical settingsMean followScreening cohortRetrospective studyRisk calculatorCancer screeningLung cancerScreening programStudy populationLung cancer detectionAmerican College
2019
Prevalence and 12-Month Downstream Costs of Incidental Findings in a Single-Center Lung Cancer Screening Program
Godfrey M, Sather P, Tanoue L, Pisani M. Prevalence and 12-Month Downstream Costs of Incidental Findings in a Single-Center Lung Cancer Screening Program. 2019, a4474-a4474. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4474.Peer-Reviewed Original ResearchLung cancer screening programsCancer screening programsIncidental findingScreening programDownstream costsPrevalenceLung cancer survival and comorbidities in lung cancer screening participants of the Gdańsk screening cohort
Ostrowski M, Marczyk M, Dziedzic R, Jelitto-Górska M, Marjański T, Pisiak S, Jędrzejczyk T, Polańska J, Zdrojewski T, Wojtyniak B, Rzyman W. Lung cancer survival and comorbidities in lung cancer screening participants of the Gdańsk screening cohort. European Journal Of Public Health 2019, 29: 1114-1117. PMID: 31004154, DOI: 10.1093/eurpub/ckz052.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary diseaseLung cancer screening programsCancer screening programsCardiovascular diseaseDiabetes mellitusLung cancerScreening programLung cancer detection rateMedical eventsModifiable risk factorsLung cancer survivalObstructive pulmonary diseaseLung cancer patientsCancer detection rateHealth care providersHealth care systemWorld Health OrganizationScreening groupHeavy smokersPulmonary diseaseScreening cohortCancer patientsCancer survivalRisk factorsCare providers
2017
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement
Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. American Journal Of Respiratory And Critical Care Medicine 2017, 196: 1202-1212. PMID: 29090963, PMCID: PMC6072613, DOI: 10.1164/rccm.201709-1858st.Peer-Reviewed Original ResearchConceptsLung cancer screening settingLung cancer screeningSmoking cessation interventionCessation interventionsCancer screeningScreening settingOfficial American Thoracic Society Research StatementComputed tomography lung cancer screeningLow-dose computed tomography (LDCT) lung cancer screeningEvidence-based smoking cessation interventionsLDCT lung cancer screeningTomography lung cancer screeningLung cancer screening programsEffective smoking cessation interventionsMultiple clinical practice guidelinesCancer screening programsTobacco dependence treatmentClinical practice guidelinesAmerican Thoracic SocietyTesting of interventionsImplementation of interventionsCessation counselingSmoking cessationLung cancerDependence treatment
2015
Components Necessary for High-Quality Lung Cancer Screening American College of Chest Physicians and American Thoracic Society Policy Statement
Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G. Components Necessary for High-Quality Lung Cancer Screening American College of Chest Physicians and American Thoracic Society Policy Statement. CHEST Journal 2015, 147: 295-303. PMID: 25356819, PMCID: PMC4502754, DOI: 10.1378/chest.14-2500.Peer-Reviewed Original ResearchConceptsLung cancer screening programsCancer screening programsLung cancer screeningAmerican Thoracic SocietyCancer screeningScreening programChest PhysiciansAmerican CollegeHigh-quality lung cancer screening programThoracic Oncology NetworkEvidence-based reviewLow-dose chest CT scansChest CT scanAmerican Cancer SocietyLung cancerComponents of screeningEssential program componentsThoracic SocietyOncology NetworkCancer SocietyCT scanProgram componentsPreventive oncologyAmerican SocietyScreening facility
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply